Evidence map›Paper›PMID 34328570›Full record

Trial reportAIDS and behavior2022

Efficacy of the Common Elements Treatment Approach (CETA) for Unhealthy Alcohol Use Among Adults with HIV in Zambia: Results from a Pilot Randomized Controlled Trial.

Jeremy C Kane, Anjali Sharma, Laura K Murray, Geetanjali Chander, Tukiya Kanguya, Stephanie Skavenski, Chipo Chitambi, Molly E Lasater, Ravi Paul, Karen Cropsey and 6 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03966885 (Zambia Common Elements Treatment Approach Pilot Study), which is not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03966885 naterminatednot on this map

Zambia Common Elements Treatment Approach Pilot Study

TypeinterventionalSponsorColumbia UniversityRan2019 to 2020Enrolled160ConditionsAlcohol Use Disorder, Depression, Post-traumatic Stress Disorder, HIV/AIDSArmsBrief Intervention, Common Elements Treatment Approach (CETA)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jeremy C KaneDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W. 168th Street, Room 519, New York, NY, 10032, USA. jk4397@cumc.columbia.edu.ORCID http://orcid.org/0000-0002-6598-3840
Anjali SharmaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Laura K MurrayDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Geetanjali ChanderJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Tukiya KanguyaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Stephanie SkavenskiDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Chipo ChitambiCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Molly E LasaterDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ravi PaulSchool of Medicine, University of Zambia, University Teaching Hospital, Lusaka, Zambia.
Karen CropseyUniversity of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Sachi InoueDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W. 168th Street, Room 519, New York, NY, 10032, USA.
Samuel BosomprahCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Carla Kmett DanielsonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Jenala ChipunguCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Francis SimendaZambia Ministry of Health, Lusaka, Zambia.
Michael J VinikoorCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Funding

Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIVK24AA027483 · NIAAA · UNIVERSITY OF WASHINGTON · PI GEETANJALI CHANDER · 2019 to 2026
$1.3M
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkersK01AA026523 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KANE, JEREMY CALVIN · 2020 to 2024
$881k
FEASIBILITY AND PRELIMINARY EFFECTIVENESS OF A TRANSDIAGNOSTIC COGNITIVE BEHAVIORAL THERAPY TREATMENT APPROACH FOR ALCOHOL MISUSE INTEGRATED WITHIN HIV CARE IN ZAMBIAR34AA027200 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI KANE, JEREMY CALVIN, VINIKOOR, MICHAEL JEFFREY · 2018 to 2020
$585k
NIAAA NIH HHS K01 AA026523NIAAA NIH HHS K01AA026523NIAAA NIH HHS K24 AA027483NIAAA NIH HHS K24AA027483NIAAA NIH HHS R34AA027200
6 · The paper itself

Abstract

This randomized controlled trial tested the efficacy of a multi-session, evidence-based, lay counselor-delivered transdiagnostic therapy, the Common Elements Treatment Approach (CETA), in reducing unhealthy alcohol use and comorbidities among persons living with HIV (PLWH) in Zambia. Adult PLWH with (a) unhealthy alcohol use plus mental health or substance use comorbidities, or (b) severe unhealthy alcohol use were randomized to receive a single-session alcohol brief intervention (BI) alone or BI plus referral to CETA. Outcomes were measured at baseline and a 6-month follow-up and included Alcohol Use Disorders Identification Test (AUDIT) score (primary), depression and trauma symptoms, and other substance use (secondary). We enrolled 160 participants; 78 were randomized to BI alone and 82 to BI plus CETA. Due to COVID-19, the trial ended early before 36 participants completed. Statistically and clinically significant reductions in mean AUDIT score from baseline to 6-month follow-up were observed in both groups, however, participants assigned to BI plus CETA had significantly greater reductions compared to BI alone (- 3.2, 95% CI - 6.2 to - 0.1; Cohen's d: 0.48). The CETA effect size for AUDIT score increased in line with increasing mental health/substance use comorbidity (0 comorbidities d = 0.25; 1-2 comorbidities d = 0.36; 3+ comorbidities d = 1.6). Significant CETA treatment effects were observed for depression, trauma, and several other substances. BI plus referral to CETA was feasible and superior to BI alone for unhealthy alcohol use among adults with HIV, particularly among those with comorbidities. Findings support future effectiveness testing of CETA for HIV outcomes among PLWH with unhealthy alcohol use.Clinical Trials Number: NCT03966885.

Indexed as

AlcoholismCOVID-19HIV InfectionsAdultHumansPilot ProjectsSARS-CoV-2ZambiaHIVRandomized controlled trialSubstance useUnhealthy alcohol useZambia

Identifiers

PMID34328570
PMCPMC8322829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.